[ASAP] PD-L1 Blockade Peptide-Modified Polymeric Nanoparticles for Oxygen-Independent-Based Hypoxic Tumor Photo/Thermodynamic Immunotherapy 🔗 Access full article via ACS Molecular Pharmaceutics The study of molecular pharmaceuticsDOI: 10.1021 / acs. Molpharmaceut. 3c00186. Share:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon
